|
Volumn 136, Issue 6, 2015, Pages 1029-1031
|
Insurance coverage of puberty blocker therapies for transgender youth
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HISTRELIN;
LEUPRORELIN;
GONADORELIN;
COST BENEFIT ANALYSIS;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ACCESS;
HEALTH CARE PERSONNEL;
HEALTH CARE POLICY;
HUMAN;
INSURANCE;
MEDICAID;
PATIENT REFERRAL;
PEDIATRIC AND ADOLESCENT GYNECOLOGY REFERRAL SERVICE;
PEDIATRIC ENDOCRINOLOGY SERVICE;
PEDIATRICS;
PHARMACY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PUBERTY;
REVIEW;
SEXISM;
TRANSGENDER;
ADOLESCENT;
AGONISTS;
DRUG EFFECTS;
FEE;
SEXUAL MATURATION;
ADOLESCENT;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
INSURANCE COVERAGE;
PRESCRIPTION FEES;
PUBERTY;
SEXUAL MATURATION;
TRANSGENDER PERSONS;
|
EID: 84948807453
PISSN: 00314005
EISSN: 10984275
Source Type: Journal
DOI: 10.1542/peds.2015-2849 Document Type: Review |
Times cited : (36)
|
References (7)
|